The amount of electricity generated from renewable energy in South Korea reached an all-time high of 7.5 percent in 2021 due to government efforts to cut greenhouse gas emissions.
According to the state-owned Korea Electric Power Corp., renewable energy sources generated 43,085 gigatonne-hours last year, accounting for 7.5 percent of overall power output in the country.
The ratio was three times larger than it had been a decade before. It was the first time the share had surpassed the 7% barrier.
The amount of power generated by solar, wind, and other renewable energy sources increased 3.5 times during the previous decade.
The substantial increase in renewable energy share came as a result of South Korea's drive to reduce greenhouse gas emissions in order to combat global warming and climate change.
Over the specified time, the proportion of power generated by liquefied natural gas increased from 22.7 percent to 29.2 percent.
Coal-fired thermal power, on the other hand, accounted for 34.3 percent of the country's electrical generation last year, down from 40.8 percent in 2011.
Due to the previous government's strategy of reducing nuclear power output, the nuclear power plant ratio fell to 27.4 percent from 31.1 percent.


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
How is Antarctica melting, exactly? Crucial details are beginning to come into focus
How ongoing deforestation is rooted in colonialism and its management practices
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Fertile land for growing vegetables is at risk — but a scientific discovery could turn the tide
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
European Markets Mixed as Pound Weakens and Major Corporate Deals Emerge
U.S. Stocks Slip as Gold Rebounds Ahead of Year-End, Markets Eye 2026 Outlook
The UK is surprisingly short of water – but more reservoirs aren’t the answer
Gold Prices Rebound in Europe as Geopolitical Tensions and Fed Outlook Support Bullion
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Oil Prices Slip Slightly as Markets Weigh Geopolitical Risks and Supply Glut Concerns
China’s Central Bank to Launch New Digital Yuan Management Framework from January 1
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



